RPRX logo

Royalty Pharma (RPRX) EV/EBITDA

EV/EBITDA:

10.81+0.07(+0.65%)
July 2, 2025

Summary

  • As of today (July 3, 2025), RPRX EV/EBITDA is 10.81, with a rise of +0.07 (+0.65%) during the most recent trading session on July 2, 2025.
  • Over the past year, RPRX EV/EBITDA has dropped by -3.59 (-24.93%).
  • RPRX EV/EBITDA is now -80.16% below its all-time high of 54.48.

Performance

RPRX EV/EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

OtherRPRXvaluation metrics

EV/EBITDA Formula

EV/EBITDA =  
Enterprise Value
TTM EBITDA

RPRX EV/EBITDA Trends

PeriodPeriodEV/EBITDAEV/EBITDAEnterprise valueEnterprise valuePricePrice
todaytoday+0.7%+0.6%+0.9%
1 m1 month+6.0%+6.0%+8.8%
3 m3 months+9.8%+9.8%+15.7%
6 m6 months-7.2%+20.1%+40.3%
ytdytd-6.8%+20.6%+41.9%
1 y1 year-24.9%+24.4%+39.8%
5 y5 years+52.0%+7.8%-20.9%

RPRX EV/EBITDA Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-month10.81at high10.20+6.0%
3 m3-month10.81at high9.76+10.8%
6 m6-month13.76-21.4%9.76+10.8%
1 y1-year15.62-30.8%9.14+18.3%
3 y3-year54.48-80.2%9.14+18.3%
5 y5-year54.48-80.2%5.90+83.2%
alltimeall time54.48-80.2%5.90+83.2%

RPRX EV/EBITDA History

DateValue
2025
10.81(-6.8%)
2024
11.60(+20.5%)
2023
9.63(-82.2%)
DateValue
2022
54.07(+239.0%)
2021
15.95(+23.8%)
2020
12.88

FAQ

  • What is Royalty Pharma EV/EBITDA?
  • What is the all time high EV/EBITDA for Royalty Pharma?
  • What is RPRX EV/EBITDA year-to-date change?
  • What is Royalty Pharma EV/EBITDA year-on-year change?

What is Royalty Pharma EV/EBITDA?

The current EV/EBITDA of RPRX is 10.81

What is the all time high EV/EBITDA for Royalty Pharma?

Royalty Pharma all-time high EV/EBITDA is 54.48

What is RPRX EV/EBITDA year-to-date change?

Royalty Pharma EV/EBITDA has changed by -0.79 (-6.81%) since the beginning of the year

What is Royalty Pharma EV/EBITDA year-on-year change?

Over the past year, RPRX EV/EBITDA has changed by -3.59 (-24.93%)
On this page